SG-292

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSG-292
Drug Alias Name2ME2 mimics (SignalGene)EMD based compounds (Nanodesign)ND classes 4-6angiogenesis inhibitors (SignalGene)anti-estrogens (Nanodesign) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanodesign Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanodesign IncSignalGene IncNovuspharma SpA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A